Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|January 1, 1982
Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazineP A Reece, I Cozamanis, R Zacest
European Journal of Clinical Pharmacology|January 1, 1983
Endralazine - a new hydralazine-like antihypertensive with high systemic bioavailabilityP A Reece, I Cozamanis, R Zacest
Journal of Chromatography|September 11, 1981
Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasmaP A Reece, I Cozamanis, R Zacest
Journal of Pharmaceutical Sciences|August 1, 1978
Interference in assays for hydralazine in humans by a major plasma metabolite, hydralazine pyruvic acid hydrazoneP A Reece, P E Stanley, R Zacest
Clinical Pharmacology and Therapeutics|September 1, 1987
Disposition of unchanged cisplatin in patients with ovarian cancerP A Reece, I Stafford, M Davy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II)P A Reece, I Stafford, J Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatinP A Reece, I Stafford, J Russell, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Prednisolone protein binding in renal transplant patientsP A Reece, A P Disney, I Stafford, et al.
Pageof 4